Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes

The COVID-19 pandemic, caused by the rapidly spreading SARS-CoV-2 virus, led to the unprecedented mobilization of scientists, resulting in the rapid development of vaccines and potential pharmaceuticals. Although COVID-19 symptoms are moderately severe in most people, in some cases the disease can r...

Descripción completa

Detalles Bibliográficos
Autores principales: Karwaciak, Iwona, Karaś, Kaja, Sałkowska, Anna, Pastwińska, Joanna, Ratajewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228867/
https://www.ncbi.nlm.nih.gov/pubmed/35744777
http://dx.doi.org/10.3390/molecules27123651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228867/
https://www.ncbi.nlm.nih.gov/pubmed/35744777
http://dx.doi.org/10.3390/molecules27123651

Ejemplares similares